Find, compare & contact
Quaternium-15
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Quaternium-15 API 4080-31-3?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Quaternium-15. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Quaternium-15
- Synonyms:
- 1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride , 3,5,7-Triaza-1-azoniaadamantane, 1-(3-chloroallyl)-, chloride , 3,5,7-Triaza-1-azoniatricyclo(3.3.1.13,7)decane, 1-(3-chloro-2-propen-1-yl)-, chloride (1:1) , Methenamine 3-chloroallylochloride , N-(3-Chloroallyl)hexaminium chloride , Quaternium 15
- Cas Number:
- 4080-31-3
- DrugBank number:
- DB14198
- Unique Ingredient Identifier:
- E40U03LEM0
General Description:
Quaternium-15, identified by CAS number 4080-31-3, is a notable compound with significant therapeutic applications. Quaternium-15 is a quaternary ammonium salt used as a surfactant and preservative in many products including cosmetics. It is an anti-microbial agent by virtue of being a formaldehyde releaser, however this can also cause contact dermatitis, a symptom of an allergic reaction, especially in those with sensitive skin. In 2005, Quaternium-15 was named in the top 15 most frequently positive allergens identified in patch tests by the North American Contact Dermatitis Group (NACDG). Sensitivity to Quaternium-15 may be identified with a clinical patch test.
Indications:
This drug is primarily indicated for: Quaternium-15 is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Classification:
Quaternium-15 belongs to the class of organic compounds known as 1,3,5-triazinanes. These are triazinanes having three nitrogen ring atoms at the 1-, 3-, and 5- positions, classified under the direct parent group 1,3,5-triazinanes. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Triazinanes class, specifically within the 1,3,5-triazinanes subclass.
Categories:
Quaternium-15 is categorized under the following therapeutic classes: Amines, Bridged-Ring Compounds, Cell-mediated Immunity, Increased Histamine Release, Polyamines, Preservatives, Pharmaceutical, Standardized Chemical Allergen. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Quaternium-15 is a type of Dermatological Agents
Dermatological agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the formulation of various skincare and dermatology products. These APIs are specifically designed to target and treat skin conditions, offering effective solutions for a wide range of dermatological concerns.
Dermatological agents encompass a diverse array of compounds, including corticosteroids, antifungal agents, antibacterials, retinoids, and immunomodulators. Each API within this category possesses unique properties and mechanisms of action, enabling them to address specific skin-related issues.
Corticosteroids, for instance, are potent anti-inflammatory agents commonly used in the treatment of skin conditions like eczema, psoriasis, and dermatitis. Antifungal agents, on the other hand, combat fungal infections such as athlete's foot or ringworm. Antibacterials are effective against bacterial infections, while retinoids promote skin cell turnover and treat acne and photoaging. Immunomodulators regulate the immune response, providing relief from conditions like atopic dermatitis.
The development and application of dermatological APIs involve rigorous research, clinical trials, and regulatory compliance. These APIs are typically integrated into topical creams, ointments, gels, and lotions, ensuring targeted delivery to the affected areas of the skin.
Dermatological agents play a crucial role in the management and treatment of various skin disorders. By harnessing the therapeutic properties of these APIs, pharmaceutical companies can develop innovative skincare products that cater to the diverse needs of individuals seeking effective dermatological solutions.
